BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
June 20, 2007
View Archived Issues
Diamyd Shares Fall On News Of Diabetes Trial Debacle
Diamyd Medical AB lost around 40 percent of its value Monday on news that it had to jettison a Phase II/III clinical trial of Diamyd, a therapeutic vaccine in development for treating autoimmune diabetes.(BioWorld International)
Read More
Bill Limiting Hybrid Embryo Research Riles UK Scientists
Read More
Genomic Activity Study Produces Some Shockers
Read More
EU Trade Leader Delivers Strong Defense For Biotech
Read More
BioInvent Seeks Added Support, More Cash To Boost Pipeline
Read More
Start-Up Finds Peptide Fix For Annual Flu Vaccine Work
Read More
Other News To Note
Read More